This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Plant Health Care 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Jeff Tweedy

최고 경영자

US$629.0k

총 보상

CEO 급여 비율	53.1%
CEO 임기	2.2yrs
CEO 소유권	0.6%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	4.8yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Jeff Tweedy 의 보수는 Plant Health Care 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Dec 31 2023	US$629k	US$334k	-US$4m
Sep 30 2023	n/a	n/a	-US$5m
Jun 30 2023	n/a	n/a	-US$6m
Mar 31 2023	n/a	n/a	-US$8m
Dec 31 2022	US$705k	US$300k	-US$9m
Sep 30 2022	n/a	n/a	-US$10m
Jun 30 2022	n/a	n/a	-US$10m
Mar 31 2022	n/a	n/a	-US$8m
Dec 31 2021	US$493k	US$272k	-US$6m
Sep 30 2021	n/a	n/a	-US$4m
Jun 30 2021	n/a	n/a	-US$2m
Mar 31 2021	n/a	n/a	-US$2m
Dec 31 2020	US$401k	US$277k	-US$3m
Sep 30 2020	n/a	n/a	-US$4m
Jun 30 2020	n/a	n/a	-US$5m
Mar 31 2020	n/a	n/a	-US$4m
Dec 31 2019	US$331k	US$260k	-US$4m
Sep 30 2019	n/a	n/a	-US$5m
Jun 30 2019	n/a	n/a	-US$5m
Mar 31 2019	n/a	n/a	-US$7m
Dec 31 2018	US$436k	n/a	-US$8m

보상 대 시장: Jeff 의 총 보상 ($USD 629.00K )은 German 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 478.33K ).

보상과 수익: Jeff 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Jeff Tweedy (56 yo)

2.2yrs

테뉴어

US$629,000

보상

Mr. Jeffrey Tweedy also known as Jeff serves as Chief Executive Officer of Plant Health Care plc since June 22, 2022. He served as Chief Operating Officer of Plant Health Care plc since 2018 until April 20...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Jeffrey Tweedy	Executive Director and CEO	4.8yrs	US$629.00k	0.57% € 204.9k
Jeffrey Hovey	CFO & Executive Director	4.8yrs	US$446.00k	0.31% € 110.9k
Katherine Coppinger	Independent Non-Executive Director	1.6yrs	US$46.00k	데이터 없음
Christopher G. Richards	Non-Executive Chairman	12yrs	US$371.00k	1.67% € 596.7k
Guy Christopher Zwanenberg	Independent Non-Executive Director	4.8yrs	US$50.00k	데이터 없음
William Lewis	Independent Non-Executive Director	9.3yrs	US$50.00k	0.28% € 98.5k

4.8yrs

평균 재임 기간

56yo

평균 연령

경험이 풍부한 이사회: PC5 의 이사회는 경험(평균 재직 기간 4.8 년)으로 간주됩니다.

This company listing is no longer active

Plant Health Care 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Plant Health Care plc, Annual General Meeting, Jun 28, 2024

Plant Health Care plc, Annual General Meeting, Jun 13, 2023

Plant Health Care plc Announces Board Appointments

Less than half of directors are independent

Plant Health Care plc, Annual General Meeting, Jun 22, 2022

Less than half of directors are independent

Recent updates

Plant Health Care Submits Application to the London Stock Exchange for the Cancellation of Admission to Trading of its Shares on AIM, Effective August 21, 2024

Plant Health Care's Shares Cancelation of Admission to Trade on AIM Effective 21 August

PI Industries Limited (BSE:523642) entered into an agreement to acquire Plant Health Care plc (PHC) from Ospraie Ag Science LLC, Lombard Odier Asset Management (Europe) Ltd. and others for £31 million.

Plant Health Care plc, Annual General Meeting, Jun 28, 2024

Plant Health Care plc Announces Expanded New California Label for Employ®

Full year 2023 earnings released: US$0.01 loss per share (vs US$0.031 loss in FY 2022)

New major risk - Revenue and earnings growth

New minor risk - Financial data availability

Plant Health Care Announces Mexico Approves PHC68949 to Control Nematodes in Vegetable Crops

Plant Health Care plc Announces Brazil Approval to Control Nematodes in Soybeans

No longer forecast to breakeven

Plant Health Care plc Provides Revenue Guidance for the Full Year to 31 December 2023 and the Full Year of Fiscal 2024

New minor risk - Share price stability

First half 2023 earnings released: US$0.008 loss per share (vs US$0.021 loss in 1H 2022)

Plant Health Care® Submits Applications to the Mexican Regulatory Agency for Approval to Commercialize the Newest Products Derived from the Company's Pretec Technology Platform (Vaccines for Plantstm), Phc25279 and Phc68949, for Use on Major Crops

New major risk - Revenue and earnings growth

Plant Health Care plc to Report First Half, 2023 Results on Sep 27, 2023

Plant Health Care®'s PHC279 Receives Federal Approval in Brazil

Plant Health Care plc Announces Approval for Sale of Harpin aß Granted in Poland

New minor risk - Shareholder dilution

Plant Health Care plc has completed a Follow-on Equity Offering in the amount of £2.794356 million.

Plant Health Care plc, Annual General Meeting, Jun 13, 2023

Plant Health Care plc Announces PHC68949 Receives Grant for First Stage of Approval in Brazil

Full year 2022 earnings released: US$0.03 loss per share (vs US$0.022 loss in FY 2021)

Plant Health Care plc Announces Board Appointments

Plant Health Care plc Announces New Products Submitted for Regulatory Approval

Forecast to breakeven in 2024

Less than half of directors are independent

Plant Health Care plc Announces Registration of Harpin in France

Plant Health Care plc Provides Earnings Guidance for the Full Year 2022

First half 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 1H 2021)

Full year 2021 earnings released: US$0.022 loss per share (vs US$0.013 loss in FY 2020)

Plant Health Care plc, Annual General Meeting, Jun 22, 2022

Less than half of directors are independent

Plant Health Care plc to Report Fiscal Year 2021 Results on May 12, 2022

Plant Health Care Submits New Application to the Us Environmental Protection Agency for Registration of Its Novel Peptide Product, PHC949

Plant Health Care plc Announces Commercial Scale Manufacturer for Saori

First half 2021 earnings released: US$0.008 loss per share (vs US$0.017 loss in 1H 2020)

Full year 2020 earnings released: US$0.01 loss per share (vs US$0.021 loss in FY 2019)

Plant Health Care plc has completed a Follow-on Equity Offering in the amount of £7.055708 million.

Plant Health Care Provides an Update on Its Most Advanced Proprietary Soybean Seed Treatment for the Prevention and Treatment of Asian Soybean Rust

Plant Health Care Announces Its New Seed Treatment, PHC279

Plant Health Care® and Wilbur-Ellis® Agribusiness Enter into Joint-Development Agreement for Pretec Products

First half earnings released

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령